The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
High-Throughput Screening of a Collection of Known Pharmacologically Active Small Compounds for Identification of Candida albicans Biofilm Inhibitors
Open accessAbstract
Candida albicans is the most common etiologic agent of systemic fungal infections with unacceptably high mortality rates. The existing arsenal of antifungal drugs is very limited and is particularly ineffective against C. albicans biofilms. To address the unmet need for novel antifungals, particularly those active against biofilms, we have screened a small molecule library consisting of 1,200 off-patent drugs already approved by the Food and Drug Administration (FDA), the Prestwick Chemical Library, to identify inhibitors of C. albicans biofilm formation. According to their pharmacological applications that are currently known, we classified these bioactive compounds as antifungal drugs, as antimicrobials/antiseptics, or as miscellaneous drugs, which we considered to be drugs with no previously characterized antifungal activity. Using a 96-well microtiter plate-based high-content screening assay, we identified 38 pharmacologically active agents that inhibit C. albicans biofilm formation. These drugs were subsequently tested for their potency and efficacy against preformed biofilms, and we identified three drugs with novel antifungal activity. Thus, repurposing FDA-approved drugs opens up a valuable new avenue for identification and potentially rapid development of antifungal agents, which are urgently needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“| Zotepine | | | | | | (High affinity to dopamine | | | | | | receptors, affects serotonin receptors, its active metabolite, | C. albicans | 0.1-40 µM (0.03-12 µg/mL) | Inhibits biofilm development | [10] |”
From Antimicrobial Properties of Antidepressants and Antipsychotics—Possibilities and Implications (2021) · cites this paper as [10]
Citations
Cites
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644
Gillum, A. M., Tsay, E. Y. H., & Kirsch, D. R. (1984) · Molecular and General Genetics MGG · doi:10.1007/bf00328721 · Cited by 1,253
Antifungal agents: mechanisms of action
Odds, F. C., Brown, A. J. P., & Gow, N. A. R. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(03)00117-3 · Cited by 1,202
Candida biofilms and their role in infection
Douglas, L. J. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(02)00002-1 · Cited by 1,150
Attributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140
Current and emerging azole antifungal agents
Sheehan, D. J., Hitchcock, C. A., & Sibley, C. M. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.1.40 · Cited by 1,137
Candida Infections of Medical Devices
Kojic, E. M., & Darouiche, R. O. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.2.255-267.2004 · Cited by 1,055
Pierce, C. G., Uppuluri, P., Tristan, A. R., Wormley, F. L., Mowat, E., Ramage, G., & Lopez-Ribot, J. L. (2008) · Nature Protocols · doi:10.1038/nprot.2008.141 · Cited by 1,041
Self-citationCalderone, R. (2012) · ASM Press eBooks · Cited by 912
Kuhn, D. M., George, T., Chandra, J., Mukherjee, P. K., & Ghannoum, M. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1773-1780.2002 · Cited by 775
Standardized Method for In Vitro Antifungal Susceptibility Testing of Candida albicans Biofilms
Ramage, G., Vande Walle, K., Wickes, B. L., & López-Ribot, J. L. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2475-2479.2001 · Cited by 753
Self-citationAmphotericin B: side effects and toxicity
Laniado-Laborín, R., & Cabrales-Vargas, M. N. (2009) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2009.06.003 · Cited by 739
Ramage, G., Saville, S. P., Thomas, D. P., & López-Ribot, J. L. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.4.633-638.2005 · Cited by 678
Self-citationBrandt, M. E. (2002) · Emerging infectious diseases · doi:10.3201/eid0808.020059 · Cited by 646
Candida biofilms on implanted biomaterials: a clinically significant problem
Ramage, G., MartÃnez, J. P., & López-Ribot, J. L. (2006) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2006.00117.x · Cited by 575
Self-citationAntifungal Resistance and New Strategies to Control Fungal Infections
Vandeputte, P., Ferrari, S., & Coste, A. T. (2011) · International Journal of Microbiology · doi:10.1155/2012/713687 · Cited by 531
Our Current Understanding of Fungal Biofilms
Ramage, G., Mowat, E., Jones, B., Williams, C., & Lopez-Ribot, J. (2009) · Critical Reviews in Microbiology · doi:10.3109/10408410903241436 · Cited by 483
Self-citationOverview of medically important antifungal azole derivatives
Fromtling, R. A. (1988) · Clinical Microbiology Reviews · doi:10.1128/cmr.1.2.187 · Cited by 400
Characteristics of biofilm formation by Candida albicans.
Ramage, G., VandeWalle, K., Wickes, B. L., & Lopez-Ribot, J. L. (2001) · PubMed · Cited by 370
Self-citationA high-throughput drug screen for Entamoeba histolytica identifies a new lead and target
Debnath, A., Parsonage, D., Andrade, R. M., He, C., Cobo, E. R., Hirata, K. K., Chen, S., García‐Rivera, G., Orozco, E., Martínez, M. B., et al. (2012) · Nature Medicine · doi:10.1038/nm.2758 · Cited by 307
In Vitro Activity of Caspofungin against Candida albicans Biofilms
Bachmann, S. P., VandeWalle, K., Ramage, G., Patterson, T. F., Wickes, B. L., Graybill, J. R., & López-Ribot, J. L. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3591-3596.2002 · Cited by 288
Self-citationMUKHERJEE, P., & Chandra, J. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.09.002 · Cited by 222
Nett, J. E., Crawford, K., Marchillo, K., & Andes, D. R. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00227-10 · Cited by 207
Amphotericin B and Its New Derivatives – Mode of Action
Bagiński, M., & Czub, J. (2009) · Current Drug Metabolism · doi:10.2174/138920009788898019 · Cited by 173
Gold compound auranofin inhibits IκB kinase (IKK) by modifying Cys-179 of IKKβ subunit
Jeon, K., Byun, M.-S., & Jue, D. (2003) · Experimental & Molecular Medicine · doi:10.1038/emm.2003.9 · Cited by 173
Prediction of Mechanisms of Action of Antibacterial Compounds by Gene Expression Profiling
Hutter, B., Schaab, C., Albrecht, S., Borgmann, M., Brunner, N. A., Freiberg, C., Ziegelbauer, K. B., Rock, C. O., Ivanov, I., & Loferer, H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.2838-2844.2004 · Cited by 149
Walraven, C. J., & Lee, S. A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01351-12 · Cited by 132
Esumi, H., Lu, J., Kurashima, Y., & Hanaoka, T. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03330.x · Cited by 127
Geier, D. A., Sykes, L. K., & Geier, M. R. (2007) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937400701389875 · Cited by 119
Biofilms of Candida albicans and their associated resistance to antifungal agents.
Ramage, G., Wickes, B. L., & Lopez-Ribot, J. L. (2001) · PubMed · Cited by 114
Self-citationZorko, M. S., & Jerala, R. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn270 · Cited by 105
Iwanaga, T., Kobayashi, D., Hirayama, M., Maeda, T., & Tamai, I. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.006056 · Cited by 103
Harder, A. (2002) · Parasitology Research · doi:10.1007/s00436-001-0587-y · Cited by 56
Chan, C.-Y., Prudom, C. E., Raines, S. M., Charkhzarrin, S., Melman, S. D., Haro, L. P. D., Allen, C., Lee, S. A., Sklar, L. A., & Parra, K. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.321133 · Cited by 54
Effect of tunicamycin on Candida albicans biofilm formation and maintenance
Pierce, C. G., Thomas, D. P., & Lopez-Ribot, J. L. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn515 · Cited by 52
Self-citationMechanisms of Anthelmintic Action
Sheth, U. K. (1975) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7090-0_19 · Cited by 44
Outcome of Antimicrobial Therapy in Documented Biofilm-Associated Infections
Falagas, M. E., Kapaskelis, A. M., Kouranos, V., Kakisi, O. K., Athanassa, Z., & Karageorgopoulos, D. E. (2009) · Drugs · doi:10.2165/00003495-200969100-00005 · Cited by 40
Bernadette, G. G., Akpa, E. E., Solange, K.-N., Natalie, G., Souleymane, B., Niamke, S. L., & Dosso, M. B. (2012) · International Journal of Microbiology · doi:10.1155/2012/150612 · Cited by 40
Quantitative Binding Models for CYP2C9 Based on Benzbromarone Analogues
Locuson, C. W., Rock, D. A., & Jones, J. P. (2004) · Biochemistry · doi:10.1021/bi049651o · Cited by 37
Katz, M. (1977) · Drugs · doi:10.2165/00003495-197713020-00002 · Cited by 35
Approaches to Design and Synthesis of Antiparasitic Drugs
(1997) · Pharmacochemistry library · doi:10.1016/s0165-7208(97)x8021-3 · Cited by 32
Chemotherapeutic approaches to nematodes: current knowledge and outlook
Harder, A. (2002) · Parasitology Research · doi:10.1007/s00436-001-0535-x · Cited by 30
A Novel Approach to Combinatorial Library Design
Nilakantan, R. (2002) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207024607310 · Cited by 27
3 Final Report on the Safety Assessment of Benzethonium Chloride and Methylbenzethonium Chloride
(1985) · Journal of the American College of Toxicology · doi:10.3109/10915818509078687 · Cited by 23
FDA Regulations for Drug Development
Behrman, R. E., & Woodcock, J. (2010) · Science · doi:10.1126/science.329.5987.33-b · Cited by 8
Yu, X., & Crites, J. L. (1990) · The Knowledge Bank (The Ohio State University) · Cited by 4
Flagged first, then by citations
1 of the 47 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Drug repurposing for antimicrobial discovery
Farha, M. A., & Brown, E. D. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0357-1 · Cited by 382
Drug repositioning and repurposing: terminology and definitions in literature
Langedijk, J., Mantel-Teeuwisse, A. K., Slijkerman, D. S., & Schutjens, M.-H. D. B. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.05.001 · Cited by 327
Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium
Arastehfar, A. A., Gabaldón, T., Garcia‐Rubio, R., Jenks, J. D., Hoenigl, M., Salzer, H. J. F., İlkit, M., Lass‐Flörl, C., & Perlin, D. S. (2020) · Antibiotics · doi:10.3390/antibiotics9120877 · Cited by 302
Mechanistic Understanding of Candida albicans Biofilm Formation and Approaches for Its Inhibition
Atriwal, T., Azeem, K., Husain, F. M., Hussain, A., Khan, M. N., Alajmi, M. F., & Abid, M. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.638609 · Cited by 222
Current Antimycotics, New Prospects, and Future Approaches to Antifungal Therapy
Wall, G., & Lopez-Ribot, J. L. (2020) · Antibiotics · doi:10.3390/antibiotics9080445 · Cited by 183
Self-citation
Metadata
- Authors
- Siles, S. A., Srinivasan, A., Pierce, C. G., Lopez-Ribot, J. L., & Ramasubramanian, A. K.
- Affiliations
- The University of Texas at San Antonio (US)
- Departments of Biology, The University of Texas at San Antonio, San Antonio, Texas, USA
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2013-08
- Volume
- 57
- Issue
- 8
- Pages
- 3681-3687
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC3719724
- OpenAlex
- W2171146043
- Cited by
- 120
- References
- 47
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 5 · 2023: 10 · 2022: 11 · 2021: 10 · 2020: 16 · 2019: 10 · 2018: 14 · 2017: 6 · 2016: 9 · 2015: 14 · 2014: 3 · 2013: 2
- FWCI
- 6.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense
- San Antonio Area Foundation
- National Heart, Lung, and Blood Institute (SC1HL112629)
- National Institute of Dental and Craniofacial Research (R01DE023510)
- Army Research Office
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- Candida albicans, biofilm formation, antibiofilm agents, antifungal drug repurposing, FDA-approved drugs, Prestwick Chemical Library, high-content screening, drug discovery, systemic fungal infection
- MeSH terms
- Amphotericin B, Antifungal Agents, Benzethonium, Candida albicans, Dimethyl Sulfoxide, Disinfectants, Dose-Response Relationship, Drug, Microbial Sensitivity Tests, Biofilms, Microbial Viability, Small Molecule Libraries, High-Throughput Screening Assays
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review